France· FR:69590806
ENVARSUS 1 mg, comprimé à libération prolongée
A medicinal product containing tacrolimus monohydraté, registered in France by CHIESI FARMACEUTICI, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TACROLIMUS MONOHYDRATÉ
- Manufacturer
- CHIESI FARMACEUTICI
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip1334009300012263 plaquette(s) thermoformée(s) PVC de 10 comprimé(s)EUR 48.58
- cip1334009495010073 plaquette(s) thermoformée(s) PVC de 10 comprimé(s) (distributeur parallèle : BB Farma)EUR 49.87
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tacrolimus monohydraté in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaENVARSUSChiesi Farmaceutici S.p.A., Parma
- SpainEnvarsus 1mg comprimidos de liberacion prolongadaChiesi Farmaceutici S.P.A.
- FinlandEnvarsusChiesi Farmaceutici S.p.A.
- United KingdomEnvarsus 1mg modified-release tabletsChiesi Ltd
- IrelandEnvarsus 1 mg prolonged-release tabletsChiesi Farmaceutici S.p.A.
- IcelandEnvarsusChiesi Farmaceutici S.p.A.*
- NetherlandsEnvarsus 1 mg, tablet met verlengde afgifteChiesi Farmaceutici S.P.A
- NorwayEnvarsusChiesi Farmaceutici S.p.a.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Adport, Dailiport
- Belgium · Adoport, Dailiport
- Bulgaria · Програф
- Cyprus · Prograf, Tacrolimus Accord
- Czechia · Dailiport, Gecrol
- Germany · Crilomus, Dailiport
- Denmark · Adport, Dailiport
- Estonia · Dailiport, Lebsanan
- Spain · Adoport, Cellmune
- Finland · Adport, Adport,
- United Kingdom (Northern Ireland) · Adoport, Ascezo
- Greece · Atodrit-Dermo, Eczatope Derm
- Croatia · Atezyrix, Dermitopic
- Hungary · Prograf, Tacrolimus Stada
- Ireland · Prograf, Tacrolimus Accord
- Iceland · Advagraf, Dailiport
- Italy · Adoport, Carelimus
- Liechtenstein · Advagraf, Envarsus
- Lithuania · Dailiport, Lebsanan
- Luxembourg · Prograft, Sumilor
- Latvia · Dailiport, Lebsanan
- Malta · Prograf
- Netherlands · Adport, Conferoport
- Norway · Adport, Advagraf
- Poland · Cidimus, Dailiport
- Portugal · Adoport, Dermitopic
- Romania · Prograf, Tacrolimus Sandoz
- Sweden · Adport, Adport,
- Slovenia · Adoport, Dailiport
- Slovakia · Atezyrix, Dailiport
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2cc2d36b-4602-4ee1-8d80-29e203837205 GET /v1/drugs/2cc2d36b-4602-4ee1-8d80-29e203837205?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69590806",
"date_amm": "2014-07-18",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/14/935",
"substance": "TACROLIMUS MONOHYDRATÉ",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé à libération prolongée",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about tacrolimus monohydraté.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.